<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="103809">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01753050</url>
  </required_header>
  <id_info>
    <org_study_id>HipHop</org_study_id>
    <secondary_id>EA1/315/12</secondary_id>
    <nct_id>NCT01753050</nct_id>
  </id_info>
  <brief_title>HIP Surgery - Hemodynamic Optimization Project</brief_title>
  <acronym>HipHop</acronym>
  <official_title>A Quality Improvement Project for Goal-directed Intraoperative Hemodynamic Optimization in Patients Redo Hip Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several studies have demonstrated that goal-directed fluid therapy during high- risk-surgery
      reduces morbidity and length of hospital stay. This quality improvement is design to
      evaluate the implementation of an intraoperative goal-directed therapy, using a pulse
      contour analysis monitor to optimize the stroke volume, in patients undergoing
      redo-hip-surgery. The primary combined endpoints will be the incidence of postoperative
      complications and the secondary endpoints will be the decrease of hospital length of stay,
      length of ICU stay and hospital postoperative mortality.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>30days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of hospital and ICU stay</measure>
    <time_frame>30days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">260</enrollment>
  <condition>Redo Hip Surgery</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No specific hemodynamic optimization measures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hemodynamic optimization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemodynamic optimization by stroke volume monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stroke volume monitoring</intervention_name>
    <description>Pulse contour stroke volume monitoring</description>
    <arm_group_label>Hemodynamic optimization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing redo hip surgery

          -  age above 18 years

          -  signed informed consent

        Exclusion Criteria:

          -  urgent or emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Medicine Campus Charit√© Mitte / Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 27, 2016</lastchanged_date>
  <firstreceived_date>December 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Sascha Treskatsch</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
